UK markets close in 1 hour 7 minutes

Genomic Vision Société Anonyme (0QT4.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.0281-0.0034 (-10.88%)
As of 04:25PM GMT. Market open.

Genomic Vision Société Anonyme

Green Square Batiment East
80-84 rue des Meuniers
Bagneux 92220
33 1 49 08 07 40

Full-time employees33

Key executives

NameTitlePayExercisedYear born
Mr. Aaron Bensimon Ph.D.Co-Founder, CEO, Chairman of Exec. Board & Scientific Director378.37kN/AN/A
Mr. Pierre SchwichChief Financial OfficerN/AN/A1953
Ms. Emilie ChataignierMember of Exec. BoardN/AN/AN/A
Mr. Frederic Hammel MBAChief Operating OfficerN/AN/AN/A
Mr. Mark David LynchGlobal Commercial & Marketing DirectorN/AN/AN/A
Ms. Claire FleuryDirector of HRN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.

Corporate governance

Genomic Vision Société Anonyme’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.